Shoreline Biosciences, Inc.
ID: 6727640Shoreline Biosciences, Inc. is a Cell-Based Immunotherapies founded in 2020 by Kleanthis G. Xanthopoulos.
4
Funding Rounds
$229.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Kl******* G. Xa********** |
|
- | - |
| St**** Ho****** |
|
- | - |
Funding series
Funding Series Analysis
The company Shoreline Biosciences, Inc. has raised a total of $183m in funding over 4 rounds.
Key Insights:
- Shoreline Biosciences, Inc. Funding Round, November 2021: $140m
- Shoreline Biosciences, Inc. , April 2021: $43m
- Shoreline Biosciences, Inc. funding round, July 2020: $3m
- Shoreline Biosciences, Inc. funding round, February 2021: $43m
Industries
Shoreline Biosciences, Inc. is active in the following industries: